Lisata Therapeutics, Inc.
LSTA· Nasdaq
LSTALisata Therapeutics, Inc.
Released Nov 7, 2016, after the close
10-Q filed Nov 7, 2016, 38 days after period end · 0000320017-16-000162
| Metric | Q3 2015 | Q3 2014 | Q3 2013 | Q3 2012 |
|---|---|---|---|---|
| Revenue | $9.32M | $5.89M | $4.12K | — |
| Net Income | -$7.29M | -$11.38K | -$16.97K | -$9.07K |
| EPS Diluted |
Lisata Therapeutics, Inc. · CIK 320017 · Engraved from SEC EDGAR
| -$1.09 |
| -$2.06 |
| -$0.48 |
| -$0.45 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
